内部人交易记录
首席执行官基于 4 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Congleton Jon, 首席执行官. Officer active across 1 company, notably Mineralys Therapeutics, Inc.. Cumulatively, 21 reports have been recorded. Split: 4 buys · 15 sells. Total volume traded: €3.7m. Activity tracked since 11 August 2023. The latest transaction was disclosed on 13 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Congleton Jon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
10,700 股@ US$27.23750.010% mcap4.5% 占其流量Common StockSEC:0001933414-26-000100:0
58,000 股Common StockSEC:0001933414-26-000096:0
17,000 股Common StockSEC:0001933414-26-000096:1
15,730 股@ US$26.82640.016% mcap11.7% 占其流量Common StockSEC:0001933414-26-000075:0
19,364 股@ US$25.50060.019% mcap13.9% 占其流量Common StockSEC:0001644975-26-000004:0
140,900 股0Common StockSEC:0001933414-26-000045:0
9,119 股@ US$32.20830.011% mcap8.2% 占其流量Common StockSEC:0001644975-26-000002:0
24,082 股@ US$0.540.3% 占其流量Common StockSEC:0001644975-25-000006:0
12,806 股@ US$41.639513.6% 占其流量Common StockSEC:0001933414-25-000151:0
13,548 股@ US$42.62950.022% mcap16.2% 占其流量Common StockSEC:0001933414-25-000129:0
15,884 股@ US$14.50716.7% 占其流量Common StockSEC:0001933414-25-000078:0
15,319 股@ US$12.19423.9% 占其流量Common StockSEC:0001933414-25-000044:0
18,333 股@ US$9.05923.8% 占其流量Common StockSEC:0001933414-25-000003:0
15,271 股@ US$13.5184.4% 占其流量Common StockSEC:0001933414-24-000045:0
15,746 股@ US$13.34154.5% 占其流量Common StockSEC:0001933414-24-000033:0
17,766 股@ US$12.25444.7% 占其流量Common StockSEC:0001933414-24-000032:0
16,607 股@ US$12.76654.6% 占其流量Common StockSEC:0001933414-24-000029:0
4,250 股@ US$5.96610.5% 占其流量Common StockSEC:0001933414-23-000093:0
2,250 股@ US$12.080.6% 占其流量Common StockSEC:0001933414-23-000067:0
2,250 股@ US$12.100.6% 占其流量Common StockSEC:0001933414-23-000065:0
2,000 股@ US$12.890.5% 占其流量Common StockSEC:0001933414-23-000061:0
About Congleton Jon
Congleton Jon is Chief Executive Officer at Mineralys Therapeutics, Inc. He has 21 filings, and across the sampled recent filings from 2023-08-11 to 2026-07-15, the aggregated amounts show EUR 97,079 of purchases and EUR 3,560,013 of sales, with disposal being the most frequent transaction type.